Method for treating migraine headaches using optically pure S(+)

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514649, 514651, A61K 31135

Patent

active

055895115

ABSTRACT:
Methods and compositions are disclosed utilizing the pure S(+) isomer of fluoxetine which is a potent antidepressant and appetite suppressant substantially free of unwanted, adverse toxic or psychological effects. In addition, methods and compositions are disclosed utilizing the pure S(+) isomer of fluoxetine which is useful in treating migraine headaches, pain, in particular chronic pain, obsessive-compulsive disorders, sexual dysfunction and memory disorders. Further, methods and compositions for treating a condition alleviated or improved by inhibition of serotonin uptake in serotonergic neurons and platelets in a human using optically pure S(+) fluoxetine are disclosed.

REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3630200 (1971-12-01), Higuchi
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4018895 (1977-04-01), Molloy et al.
patent: 4194009 (1980-03-01), Molloy et al.
patent: 4313896 (1982-02-01), Molloy et al.
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4329356 (1982-05-01), Holland
patent: 4444778 (1984-04-01), Coughlin
patent: 4590213 (1986-05-01), Stark
patent: 4594358 (1986-06-01), Hynes
patent: 4596807 (1986-06-01), Crosby
patent: 4626549 (1986-12-01), Molloy et al.
patent: 4647591 (1987-03-01), Cherkin et al.
patent: 4698342 (1987-10-01), Crosby
patent: 4777173 (1988-10-01), Shrotryia et al.
patent: 4797286 (1989-01-01), Thakkar et al.
patent: 4847092 (1989-07-01), Thakkar et al.
patent: 4868344 (1989-09-01), Brown
patent: 4895845 (1990-01-01), Seed
patent: 4918207 (1990-04-01), Brown
patent: 4918242 (1990-04-01), Brown
patent: 4918246 (1990-04-01), Brown
patent: 5114976 (1992-05-01), Norden
patent: 5250571 (1993-10-01), Fuller et al.
patent: 5356934 (1994-10-01), Robertson et al.
Caccia et al., "Influence of Dose and Route of Administration on the Kinetics of Fluoxetine and Its Metabolite Norfluoxetine in the Rat", Psychopharmacology, 100: 509-514 (1990).
Teicher et al., "Emergence of Intense Suicidal Preoccupation During Fluoxetine Treatment", Am. J. Psychiatry, 147(2): 207-210 (1990).
Wong et al., "Fluoxetine and Its Two Enantiomers as Selective Serotonin Uptake Inhibitors", Acta Pharm. Nord., 2(3): 171-180 (1990).
Corey and Reichard, "Enantioselective and Practical Syntheses of R-and S-Fluoxetines", Tetrahedron Lett., 30(39): 5207-5210 (1989).
Coutts and Baker, "Implications of Chirality and Geometric Isomerism in Some Psychoactive Drugs and Their Metabolites", Chirality, 1:99-120 (1989).
Coutts and Baker, "Metabolic Implications of Chiral Centres in Psychotropic Drugs", Prog. Neuro-Psychopharmacol. & Biol. Psychiat., 13: 405-417 (1989).
Jamali et al., "Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls", J. Pharm. Sci. 78(9): 695-715 (1989).
Gao and Sharpless, "Asymmetric Synthesis of both Enantiomers of Tomoxetine and Fluoxetine. Selective Reduction of 2,3-Epoxycinnamyl Alcohol with Red-Al", J. Org. Chem., 53(17): 4081-4084 (1988).
Kim and Wurtman, "Selective Effects of CGS 10686B, d1-Fenfluramine or Fluoxetine on Nutrient Selection", Physiology & Behavior, 42: 319-322 (1988).
Robertson et al., "Absolute Configurations and Pharmacological Activities of the Optical Isomers of Fluoxetine, a Selective Serotonin-Uptake Inhibitor", J. Med. Chem., 31: 1412-1417 (1988).
Wong et al., "Suppression of Food Intake in Rats by Fluoxetine: Comparison of Enantiomers and Effects of Serotonin Antagonists", Pharmacology Biochemistry & Behavior, 31: 475-479 (1988).
Benfield et al., "Fluoxetine: A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Depressive Illness", Drugs 32: 481-508 (1986).
Fuller and Snoddy, "Fluoxetine Enantiomers as Antagonists of p-Chloroamphetamine Effects in Rats", Pharmacology Biochemistry & Behavior, 24: 281-284 (1986).
Scrip's New Product Review, No. 7, pp. 13-14 (1986).
Wong et al., "Inhibition of Serotonin Uptake by Optical Isomers of Fluoxetine", Drug Development Research, 6: 397-403 (1985).
Chem Abstract 112 216327E (1990).
Bremner, "Fluoxetine in Depressed Patients: A Comparison with Imipramine", J. Clin. Psychiatry, 45(10): 414-420 (1984).
Power-Smith, "Beneficial Sexual Side-effects from Fluoxetine," Brit. J. Psychiatry 164: 249-250 (1994).
Saper et al., "Double-Blind Trial of Fluoxetine: Chronic Daily Headache and Migraine," Headache 34: 497-502 (1994).
Stevens et al., "Interaction of the Enantiomers of Fluoxetine and Norfluoxetine with Human Liver Cytochromes P450," J. Pharmacology & Experimental Therapeutics 226(7): 964-971 (1993).
Adly et al., "Fluoxetine Prophylaxis of Migraine," Headache 32: 101-104 (1992).
Bergstrom et al., "Quantification and Mechanism of the Fluoxetine and Tricyclic Antidepressant Interaction," Clin. Pharmacol. Ther. 51: 239-248 (1992).
Physicians Desk Reference, pp. 905-908, 44th Ed., Medical Economics Data Production Co., N.J. (1990).
Roberston et al. J. Med. Chem 1988. 31, 1412-1417.
Wong et al. Acta Pharm. Nord. 2(3) 1990. pp. 171-180.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for treating migraine headaches using optically pure S(+) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating migraine headaches using optically pure S(+), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating migraine headaches using optically pure S(+) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1142533

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.